Logo image of MNDT

MANDIANT INC (MNDT) Stock Fundamental Analysis

NASDAQ:MNDT - Nasdaq - US5626621065 - Common Stock - Currency: USD

22.98  +0.12 (+0.52%)

After market: 22.98 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MNDT. MNDT was compared to 283 industry peers in the Software industry. While MNDT seems to be doing ok healthwise, there are quite some concerns on its profitability. MNDT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MNDT had negative earnings in the past year.
MNDT Yearly Net Income VS EBIT VS OCF VS FCFMNDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 500M

1.2 Ratios

Industry RankSector Rank
ROA 27.93%
ROE 47.94%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNDT Yearly ROA, ROE, ROICMNDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 20 -20 40 -40

1.3 Margins

Industry RankSector Rank
OM -65.41%
PM (TTM) 162.35%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MNDT Yearly Profit, Operating, Gross MarginsMNDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 50 -50 100 150

More info and screens

4

2. Health

2.1 Basic Checks

MNDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
MNDT has less shares outstanding than it did 1 year ago.
MNDT has a better debt/assets ratio than last year.
MNDT Yearly Shares OutstandingMNDT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M
MNDT Yearly Total Debt VS Total AssetsMNDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 1B 2B 3B

2.2 Solvency

An Altman-Z score of 1.97 indicates that MNDT is not a great score, but indicates only limited risk for bankruptcy at the moment.
MNDT has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACCN/A
WACC7.82%
MNDT Yearly LT Debt VS Equity VS FCFMNDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 3.67 indicates that MNDT has no problem at all paying its short term obligations.
A Quick Ratio of 3.67 indicates that MNDT has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 3.67
Quick Ratio 3.67
MNDT Yearly Current Assets VS Current LiabilitesMNDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for MNDT have decreased strongly by -177.50% in the last year.
The Revenue has decreased by -9.42% in the past year.
The Revenue has been decreasing by -7.29% on average over the past years.
EPS 1Y (TTM)-177.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-244.44%
Revenue 1Y (TTM)-9.42%
Revenue growth 3Y-16.52%
Revenue growth 5Y-7.29%
Sales Q2Q%21.08%

3.2 Future

Based on estimates for the next years, MNDT will show a very negative growth in Earnings Per Share. The EPS will decrease by -57.22% on average per year.
MNDT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.18% yearly.
EPS Next Y-426.98%
EPS Next 2Y-68.06%
EPS Next 3Y-39.76%
EPS Next 5Y-57.22%
Revenue Next Year16.11%
Revenue Next 2Y19.49%
Revenue Next 3Y20.72%
Revenue Next 5Y21.18%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MNDT Yearly Revenue VS EstimatesMNDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
MNDT Yearly EPS VS EstimatesMNDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MNDT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MNDT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MNDT Price Earnings VS Forward Price EarningsMNDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -16.87
MNDT Per share dataMNDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

MNDT's earnings are expected to decrease with -39.76% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.06%
EPS Next 3Y-39.76%

More info and screens

0

5. Dividend

5.1 Amount

MNDT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MANDIANT INC

NASDAQ:MNDT (9/9/2022, 8:00:01 PM)

After market: 22.98 0 (0%)

22.98

+0.12 (+0.52%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-02 2022-08-02/amc
Earnings (Next)11-02 2022-11-02
Inst Owners0%
Inst Owner Change0%
Ins Owners0%
Ins Owner Change0%
Market Cap5.40B
Analysts49.09
Price Target20.91 (-9.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.32
P/FCF N/A
P/OCF N/A
P/B 3.05
P/tB N/A
EV/EBITDA -16.87
EPS(TTM)-0.31
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.23
BVpS7.54
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 27.93%
ROE 47.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -65.41%
PM (TTM) 162.35%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.67
Quick Ratio 3.67
Altman-Z 1.97
F-Score4
WACC7.82%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-177.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-244.44%
EPS Next Y-426.98%
EPS Next 2Y-68.06%
EPS Next 3Y-39.76%
EPS Next 5Y-57.22%
Revenue 1Y (TTM)-9.42%
Revenue growth 3Y-16.52%
Revenue growth 5Y-7.29%
Sales Q2Q%21.08%
Revenue Next Year16.11%
Revenue Next 2Y19.49%
Revenue Next 3Y20.72%
Revenue Next 5Y21.18%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A